Esprit To Market Estrogen Therapy Estrasorb In 2006
The company gains rights to Novavax' topical estrogen therapy Estrasorb after the failure of Novavax' copromotion deal with King.
The company gains rights to Novavax' topical estrogen therapy Estrasorb after the failure of Novavax' copromotion deal with King.